DiscoverRx for BiotechHow ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes
How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes

How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes

Update: 2023-09-07
Share

Description

In this podcast episode, our guest is Mark McDonough, CEO of ChromaCode.

ChromaCode is an innovator in genomics with a multiplexing platform that is driving integration from laboratories to physicians to patients, connecting them to the right treatment through its proven HDPCR™ multiplexing platform. This adaptable technology expands the accessibility of diagnostic applications to patient communities with a cost effective and scalable dPCR-based solution compatible with existing instrumentation and using standard workflows
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes

How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes

Podcast Host Chris Leidli